Glucose and Blood Pressure-Dependent Pathways–The Progression of Diabetic Kidney Disease

by Devang M. Patel, Madhura Bose, Mark E. Cooper
Published 2020-03-01

Amylin in the Periphery

by Peter J. Wookey, Loredanna Xuereb, Christos Tikellis, Mark E. Cooper
Published 2003-01-01

Role of Cell Division Autoantigen 1 (CDA1) in Cell Proliferation and Fibrosis

by Zhonglin Chai, Mark E. Cooper, Zemin Cao, Ban-Hock Toh, Yugang Tu
Published 2010-09-01

Sex Differences in Biopsy-Confirmed Diabetic Kidney Disease

by Yiting Wang, Jue Zhang, Junlin Zhang, Yucheng Wu, Rui Zhang, Honghong Ren, Mark E. Cooper, Fang Liu
Published 2021-07-01

clipped kidney of Goldblatt rats. Kidney Int (in press). The role of the (pro)renin receptor in developing ischaemic and diabetic retina

by Jennifer L Wilkinson-Berka, Ronen Heine, Genevieve Tan, Chris Tikellis, Mark E Cooper, Genevieve Nguyen, Antonia G Miller
Published 2008-03-01

DNA methylation status correlates with adult β-cell regeneration capacity

by Ishant Khurana, Keith Al-Hasani, Scott Maxwell, Harikrishnan K.N., Jun Okabe, Mark E. Cooper, Patrick Collombat, Assam El-Osta
Published 2021-02-01

Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease

by Anna M. D. Watson, Anna M. D. Watson, Eleanor A. M. Gould, Sarah C. Moody, Priyadharshini Sivakumaran, Karly C. Sourris, Bryna S. M. Chow, Audrey Koïtka-Weber, Terri J. Allen, Karin A. M. Jandeleit-Dahm, Karin A. M. Jandeleit-Dahm, Mark E. Cooper, Mark E. Cooper, Anna C. Calkin, Anna C. Calkin
Published 2020-06-01

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor

by Megumi Oshima, Akinori Hara, Tadashi Toyama, Min Jun, Carol Pollock, Meg Jardine, Stephen Harrap, Neil Poulter, Mark E. Cooper, Mark Woodward, John Chalmers, Vlado Perkovic, Muh Geot Wong, Takashi Wada
Published 2021-02-01

Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus

by Honghong Ren, Lijun Zhao, Yutong Zou, Yiting Wang, Junlin Zhang, Yucheng Wu, Rui Zhang, Tingli Wang, Jiali Wang, Yitao Zhu, Ruikun Guo, Huan Xu, Lin Li, Mark E. Cooper, Fang Liu
Published 2021-01-01

Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide

by Sih Min Tan, Runa S. J. Lindblom, Mark Ziemann, Adrienne Laskowski, Cesare Granata, Matthew Snelson, Vicki Thallas-Bonke, Assam El-Osta, Carlos D. Baeza-Garza, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Mark E. Cooper, Michael P. Murphy, Melinda T. Coughlan
Published 2021-04-01

Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets

by Lining Ju, James D. McFadyen, Saheb Al-Daher, Imala Alwis, Yunfeng Chen, Lotte L. Tønnesen, Sophie Maiocchi, Brianna Coulter, Anna C. Calkin, Eric I. Felner, Neale Cohen, Yuping Yuan, Simone M. Schoenwaelder, Mark E. Cooper, Cheng Zhu, Shaun P. Jackson
Published 2018-03-01

Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placeb...

by Julio Rosenstock, Vlado Perkovic, John H. Alexander, Mark E. Cooper, Nikolaus Marx, Michael J. Pencina, Robert D. Toto, Christoph Wanner, Bernard Zinman, David Baanstra, Egon Pfarr, Michaela Mattheus, Uli C. Broedl, Hans-Juergen Woerle, Jyothis T. George, Maximilian von Eynatten, Darren K. McGuire, CARMELINA® investigators
Published 2018-03-01

The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

by Barry M Brenner, Mark E Cooper, Dick de Zeeuw, Jean-Pierre Grunfeld, William F Keane, Kiyoshi Kurokawa, Janet B McGill, William E Mitch, Hans Henrik Parving, Guiseppe Remuzzi, Arthur B Ribeiro, Mark D Schluchter, Duane Snavely, Zhongxin Zhang, Roger Simpson, Denise Ramjit, Shahnaz Shahinfar, RENAAL Study Investigators
Published 2000-12-01

Solidified glomerulosclerosis, identified using single glomerular proteomics, predicts end-stage renal disease in Chinese patients with type 2 diabetes

by Lijun Zhao, Fang Liu, Lin Li, Junlin Zhang, Tingli Wang, Rui Zhang, Wei Zhang, Xiaoyan Yang, Xiaoxi Zeng, Yiting Wang, Yucheng Wu, Hao Yang, Shisheng Wang, Yi Zhong, Huan Xu, Shanshan Wang, Ruikun Guo, Honghong Ren, Lichuan Yang, Baihai Su, Jie Zhang, Nanwei Tong, Xin J. Zhou, Mark E. Cooper
Published 2021-02-01

Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes

by Jack Wei Chieh Tan, David Sim, Junya Ako, Wael Almahmeed, Mark E Cooper, Jamshed J Dalal, Chaicharn Deerochanawong, David Wei Chun Huang, Sofian Johar, Upendra Kaul, Sin Gon Kim, Natalie Koh, Alice Pik-Shan Kong, Rungroj Krittayaphong, Bernard Kwok, Bien J Matawaran, Quang Ngoc Nguyen, Loke Meng Ong, Jin Joo Park, Yongde Peng, David KL Quek, Ketut Suastika, Norlela Sukor, Boon Wee Teo, Chee Kiang Teoh, Jian Zhang, Eugenio B Reyes, Su Yen Goh
Published 2021-04-01